N@N

CPRX, KBW, DVR, UA, OMPI, UPL Are Seasonally Ripe To Go Up In the Next Five Weeks

September 7, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Catalyst Pharmaceutical Partners Inc (NASDAQ:CPRX), KBW Inc (NYSE:KBW), Cal Dive International Inc (NYSE:DVR), Under Armour Inc (NYSE:UA), Obagi Medical Products Inc (NASDAQ:OMPI), Ultra Petroleum Corp (NYSE:UPL) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  CPRX    Catalyst Pharmaceutical Partners Inc  6.60%            100.00% (5 of 5)     Monday, September 10th 2012
  KBW     KBW Inc                          13.89%           100.00% (5 of 5)     Wednesday, October 3rd 2012
  DVR     Cal Dive International Inc       7.52%            100.00% (5 of 5)     Thursday, September 13th 2012
  UA      Under Armour Inc                 15.19%           100.00% (6 of 6)     Monday, September 17th 2012
  OMPI    Obagi Medical Products Inc       8.63%            100.00% (5 of 5)     Tuesday, September 25th 2012
  UPL     Ultra Petroleum Corp             14.01%           81.82% (9 of 11)     Wednesday, October 17th 2012

Catalyst Pharmaceutical Partners Inc (NASDAQ:CPRX) - Catalyst Pharmaceutical Partners, Inc., a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. It is evaluating its lead product candidate, CPP-109, a GABA aminotransferase inhibitor, which is under Phase II(b) clinical trial for the treatment of cocaine addiction, as well as focuses on evaluating CPP-109 for the treatment of other addictions and obsessive-compulsive disorders. The company is also developing CPP-115, a GABA aminotransferase inhibitor for various indications, including epilepsy and drug addiction. It has license agreements with Brookhaven Science Associates, LLC on various patents and patent applications relating to the use of vigabatrin as a treatment for cocaine and other addictions, and obsessive-compulsive disorders; and with Northwestern University to commercialize GABA aminotransferase inhibitors worldwide. Catalyst Pharmaceutical Partners, Inc. was founded in 2002 and is based in Coral Gables, Florida.

KBW Inc (NYSE:KBW) - KBW, Inc., through its subsidiaries, operates as an investment bank specializing in the financial services industry in the United States and Europe. It provides various investment banking services, including mergers and acquisitions and other strategic advisory services, equity and fixed income securities offerings, and mutual thrift conversions; and equity and fixed income sales and trading. The company also offers research services comprising fundamental and objective analysis that identifies investment opportunities and assists investor to make investment decisions; and asset management services consisting of investment management and other advisory services to institutional clients, private high net worth clients, and various investment vehicles. It serves bank and thrift holding companies, banking and insurance companies, thrift institutions, broker-dealers, mortgage banks, asset management companies, mortgage and equity real estate investment trusts, consumer and specialty finance firms, financial processing companies, and securities exchanges. The company was founded in 1962 and is headquartered in New York, New York.

Cal Dive International Inc (NYSE:DVR) - Cal Dive International Inc., a marine contractor, provides manned diving, pipe laying, and pipe-burial services to the offshore oil and natural gas industry. The company offers saturation, surface, and mixed gas diving services. Cal Dive also provides such diving-support services as construction, inspection, maintenance, repair, and decommissioning of offshore production and pipeline infrastructure on the Gulf of Mexico Outer Continental Shelf as well as in international offshore markets, including the Mideast, southeast Asia, and Australia. Its customers include oil and natural gas producers, pipeline transmission companies, and offshore engineering and construction outfits. As of Dec. 31, 2006, Cal Dive owned and operated a fleet of 26 vessels, including 23 surface and saturation diving support vessels as well as three shallow water pipe-laying vessels. The company, which was founded in 1975, is based in Houston.

Under Armour Inc (NYSE:UA) - Under Armour Inc. designs, develops, markets, and distributes a range of apparel and accessories using synthetic microfiber fabrications in the U.S. and internationally. Its products for men, women, and youth extend across the sporting goods, outdoor, and active lifestyle markets and come in three fit types: compression (tight-fitting), fitted (athletic cut), and loose (relaxed) for use by professional football, baseball, hockey, and soccer players, as well as athletes. It offers T-shirts, sweats, socks, performance bags, baseball batting gloves, football gloves and cleats, and other related products; and products for use in outdoor activities, such as hunting, fishing, and mountain sports. The company was founded in 1995 and is headquartered in Baltimore.

Obagi Medical Products Inc (NASDAQ:OMPI) - Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets topical aesthetic and therapeutic prescription skin care systems in the United States and internationally. It offers Obagi Nu-Derm System, which includes prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo-damage, hyperpigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems that are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System, a combination of prescription, OTC drugs, and adjunctive cosmetic skin care products to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Obagi Professional-C products, a line of proprietary, non-prescription products, which consist of vitamin C serums used to reduce the appearance of damage to the skin caused by ultraviolet radiation and other environmental influences. The company also provides ELASTIderm Eye and Decolletage, which increase the elasticity and skin tone of eyes, face, neckline, and chest; CLENZIderm M.D. Systems used for the treatment of acne; Obagi Rosaclear System used for the treatment of rosacea; Tretinoin used for the treatment of acne; Refissa used for the treatment of fine facial lines, hyperpigmentation, and tactile roughness; Metronidazole, an antibiotic used for the treatment of rosacea in the United States; and Obagi Blue Peel System used for the treatment of fine lines, wrinkles, and hyperpigmentation. In addition, it licenses certain non-prescription product concepts to Japanese based pharmaceutical companies for sale in Japan under the Obagi trademark. Obagi Medical Products, Inc. sells its products through own domestic sales force and foreign distributors to dermatologists, plastic surgeons, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Long Beach, California.

Ultra Petroleum Corp (NYSE:UPL) - Ultra Petroleum Corp., an independent oil and gas company, engages in the acquisition, exploration, development, production, and operation of oil and natural gas properties. It primarily focuses on developing and expanding a tight gas sand trend located in the Green River Basin in southwest Wyoming; and exploring, developing, and expanding its position in the Marcellus Shale in the north-central Pennsylvania area of the Appalachian Basin. As of December 31, 2009, the company owned interests in approximately 56,000 net acres in Wyoming; and 169,000 net acres in Pennsylvania. Ultra Petroleum Corp. was founded in 1979 and is based in Houston, Texas.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641